[go: up one dir, main page]

Heartlein et al., 1994 - Google Patents

Long-term production and delivery of human growth hormone in vivo.

Heartlein et al., 1994

View PDF
Document ID
8607237926933961567
Author
Heartlein M
Roman V
Jiang J
Sellers J
Zuliani A
Treco D
Selden R
Publication year
Publication venue
Proceedings of the National Academy of Sciences

External Links

Snippet

The application of somatic cell gene therapy to large patient populations will require the development of safe and practical approaches to the generation and characterization of genetically manipulated cells. Transkaryotic implantation is a gene therapy system based on …
Continue reading at www.pnas.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/04—Uses of viruses as vector in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system

Similar Documents

Publication Publication Date Title
Heartlein et al. Long-term production and delivery of human growth hormone in vivo.
US6537542B1 (en) Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production
Takamiya et al. An experimental model of retrovirus gene therapy for malignant brain tumors
EP0649464B1 (en) Transfection of vertebrate cells e.g. by homologous recombination
KR100379356B1 (en) DNA constructs and their uses to achieve homologous recombination
Friedmann Gene therapy for neurological disorders
Vrancken Peeters et al. Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer
US6410314B1 (en) Episomally replicating vector, its preparation and use
RU2198683C2 (en) Self-regulating apoptosis of inflammatory cells using genetic therapy
EP1066395B1 (en) Inducible alphaviral gene expression system
WO1995025169A1 (en) CHIMERIC GENE USING THE GENE OR cDNA OF INSULINE, SPECIALLY FOR THE GENE THERAPY OF DIABETES
WO1994020629A1 (en) Eukaryotic expression vectors driven by a myosin heavy chain gene promoter
WO2000031267A1 (en) Insulin production by engineered muscle cells
US6531124B1 (en) In vivo production and delivery of insulinotropin for gene therapy
AU753372B2 (en) Transfection of vertebrate cells e.g. by homologous recombination
JPS6344898A (en) Production of human antithrombin 3 (AT3)
Escarti-Nebot et al. 860. Sustained Long_Term In Vivo Expression of Human Factor IX from Keratinocytes Transduced with HIV_Based Vectors
Crawford et al. 861. Recombinant Adeno_Associated Virus Vector Mediated Gene Therapy of Adenosine Deaminase Deficiency in a Mouse Model
Monastersky et al. Gene Transfer Technology: Alternative Techniques and Applications
EP1218523A1 (en) Targeted gene therapy
HK1047296A (en) Transfection of vertebrate cells e.g. by homologous recombination
HK1014033B (en) Dna constructs and transfection of cells therewith for homologous recombination
JP2000302696A (en) Composition for introducing oligodendrocyte-specific gene
MXPA00008367A (en) Self-regulated apoptosis of inflammatory cells by gene therapy